Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Structural weakening of the colonic mucus barrier is an early event in ulcerative colitis pathogenesis
Sjoerd van der Post, Karolina S. Jabbar, George Birchenough, et al.
Gut (2019) Vol. 68, Iss. 12, pp. 2142-2151
Open Access | Times Cited: 389

Showing 26-50 of 389 citing articles:

Gut microbiota derived bile acid metabolites maintain the homeostasis of gut and systemic immunity
Lei Su, Yunhuan Gao, Rongcun Yang
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 54
The gut commensal Blautia maintains colonic mucus function under low-fiber consumption through secretion of short-chain fatty acids
Sandra Holmberg, R Feeney, V. K., et al.
Nature Communications (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 46
Microbiota and mucosal defense in IBD: an update
Eduard F. Stange, Bjoern O. Schroeder
Expert Review of Gastroenterology & Hepatology (2019) Vol. 13, Iss. 10, pp. 963-976
Open Access | Times Cited: 131
Oral nanomedicine for modulating immunity, intestinal barrier functions, and gut microbiome
Yonghyun Lee, Nobuhiko Kamada, James J. Moon
Advanced Drug Delivery Reviews (2021) Vol. 179, pp. 114021-114021
Open Access | Times Cited: 96
Hesperetin ameliorates DSS-induced colitis by maintaining the epithelial barrier via blocking RIPK3/MLKL necroptosis signaling
Jixiang Zhang, Hongbo Lei, Xue Hu, et al.
European Journal of Pharmacology (2020) Vol. 873, pp. 172992-172992
Closed Access | Times Cited: 94
Use of Faecal Transplantation with a Novel Diet for Mild to Moderate Active Ulcerative Colitis: The CRAFT UC Randomised Controlled Trial
Chen Sarbagili‐Shabat, Franco Scaldaferri, Eran Zittan, et al.
Journal of Crohn s and Colitis (2021) Vol. 16, Iss. 3, pp. 369-378
Open Access | Times Cited: 80
5-Aminosalicylic acid ameliorates dextran sulfate sodium-induced colitis in mice by modulating gut microbiota and bile acid metabolism
Ling Huang, Junping Zheng, Guangjun Sun, et al.
Cellular and Molecular Life Sciences (2022) Vol. 79, Iss. 8
Closed Access | Times Cited: 70
Diet, microbiota, and the mucus layer: The guardians of our health
Francesco Suriano, Elisabeth Nyström, Domenico Sergi, et al.
Frontiers in Immunology (2022) Vol. 13
Open Access | Times Cited: 68
Gut microbiome-mediated metabolism effects on immunity in rural and urban African populations
Martin Stražar, Godfrey S. Temba, Hera Vlamakis, et al.
Nature Communications (2021) Vol. 12, Iss. 1
Open Access | Times Cited: 61
Intestinal mucus barrier: a missing piece of the puzzle in food allergy
Amy Parrish, Marie Boudaud, Annette Kuehn, et al.
Trends in Molecular Medicine (2021) Vol. 28, Iss. 1, pp. 36-50
Open Access | Times Cited: 58
Untangling Mucosal Drug Delivery: Engineering, Designing, and Testing Nanoparticles to Overcome the Mucus Barrier
Jeffrey Watchorn, Aaron J. Clasky, Gayatri Prakash, et al.
ACS Biomaterials Science & Engineering (2022) Vol. 8, Iss. 4, pp. 1396-1426
Closed Access | Times Cited: 54
Mucus, commensals, and the immune system
Qing Zhao, Craig L. Maynard
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 51
Microbial hydrogen economy alleviates colitis by reprogramming colonocyte metabolism and reinforcing intestinal barrier
Li Ge, Jie Qi, Bo Shao, et al.
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 47
The barrier and beyond: Roles of intestinal mucus and mucin-type O-glycosylation in resistance and tolerance defense strategies guiding host-microbe symbiosis
Kirk Bergstrom, Lijun Xia
Gut Microbes (2022) Vol. 14, Iss. 1
Open Access | Times Cited: 44
Transglutaminase 3 crosslinks the secreted gel-forming mucus component Mucin-2 and stabilizes the colonic mucus layer
Jack D. A. Sharpen, Brendan Dolan, Elisabeth Nyström, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 43
The epithelial-specific ER stress sensor ERN2/IRE1β enables host-microbiota crosstalk to affect colon goblet cell development
Michael J. Grey, Heidi De Luca, Doyle V. Ward, et al.
Journal of Clinical Investigation (2022) Vol. 132, Iss. 17
Open Access | Times Cited: 42
Enhancing intestinal barrier efficiency: A novel metabolic diseases therapy
Yaoyuan Zhang, Zhu Xiao, Xinyuan Yu, et al.
Frontiers in Nutrition (2023) Vol. 10
Open Access | Times Cited: 42
Bacterial biofilms in the human body: prevalence and impacts on health and disease
Elena K. Perry, Man‐Wah Tan
Frontiers in Cellular and Infection Microbiology (2023) Vol. 13
Open Access | Times Cited: 42
Revealing proteome-level functional redundancy in the human gut microbiome using ultra-deep metaproteomics
Leyuan Li, Tong Wang, Zhibin Ning, et al.
Nature Communications (2023) Vol. 14, Iss. 1
Open Access | Times Cited: 40
A β-N-acetylhexosaminidase Amuc_2109 from Akkermansia muciniphila protects against dextran sulfate sodium-induced colitis in mice by enhancing intestinal barrier and modulating gut microbiota
Kaiyue Qian, Shoujun Chen, Junchao Wang, et al.
Food & Function (2022) Vol. 13, Iss. 4, pp. 2216-2227
Closed Access | Times Cited: 39
Dietary flavonoids and gut microbiota interaction: A focus on animal and human studies to maximize their health benefits
Yang Li, Yongchao Gao, Mohamed A. Farag, et al.
Food Frontiers (2023) Vol. 4, Iss. 4, pp. 1794-1809
Open Access | Times Cited: 37
Modified Gegen Qinlian decoction ameliorates DSS-induced chronic colitis in mice by restoring the intestinal mucus barrier and inhibiting the activation of γδT17 cells
Jing Ma, Jiaqi Zhang, Yifan Wang, et al.
Phytomedicine (2023) Vol. 111, pp. 154660-154660
Open Access | Times Cited: 35
Intestinal Barrier Dysfunction in Inflammatory Bowel Disease: Underpinning Pathogenesis and Therapeutics
Katie A. Dunleavy, Laura E. Raffals, Michael Camilleri
Digestive Diseases and Sciences (2023) Vol. 68, Iss. 12, pp. 4306-4320
Open Access | Times Cited: 29
Longan pulp polysaccharides regulate gut microbiota and metabolites to protect intestinal epithelial barrier
Yajuan Bai, Yue Zhou, Xiang Li, et al.
Food Chemistry (2023) Vol. 422, pp. 136225-136225
Closed Access | Times Cited: 27
Manipulating Microbiota in Inflammatory Bowel Disease Treatment: Clinical and Natural Product Interventions Explored
Mengjie Zhu, Yijie Song, Yu Xu, et al.
International Journal of Molecular Sciences (2023) Vol. 24, Iss. 13, pp. 11004-11004
Open Access | Times Cited: 27

Scroll to top